nach oben

Die Ophthalmologie

Erschienen in:

07.10.2020 | Glaukom | Leitthema

Vaskuläre Therapiekonzepte bei Glaukompatienten

verfasst von: Priv.-Doz. Dr. med. Karin R. Pillunat, Lutz E. Pillunat

Erschienen in: Die Ophthalmologie | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hintergrund

Etwa 40 % der Offenwinkelglaukome gehen mit einem normalen Augeninnendruck einher. Bei diesen spielen vaskuläre Faktoren eine vordergründige Rolle in der Pathogenese. Aber auch Offenwinkelglaukome mit einem höheren Augeninnendruck haben oft beträchtliche vaskuläre Komponenten.

Fragestellung

Welche praxisrelevanten Möglichkeiten der vaskulären Glaukomtherapie gibt es?

Material und Methode

Es erfolgte eine Auswertung der in PubMed verfügbaren Literatur zu dem Thema.

Ergebnisse

Die Behandlung vaskulärer Risikofaktoren beim Glaukompatienten setzt neben einer genauen Anamnese hinsichtlich vaskulärer Faktoren (kalte Akren, Tinnitus, Migräne etc.) die Erfassung der vorhandenen systemischen Erkrankungen voraus. Die Ermittlung eines 24-h-Blutdruckprofils sowie die Bestimmung des Lipidstatus stellen weitere, einfach durchzuführende Untersuchungen dar.

Schlussfolgerung

Neben der Optimierung des systemischen Blutdrucks sind die Optimierung eines erhöhten Venendrucks, die Behandlung mit Statinen, Kalziumantagonisten, Ginkgo biloba und vermehrte sportliche Aktivität und Flüssigkeitszufuhr mögliche Therapieansätze. Die interdisziplinäre Zusammenarbeit mit dem Hausarzt oder Internisten ist ein wichtiger Teil einer ganzheitlichen Therapie.

von Graefe A (1857) Über die Iridectomie bei Glaucom und über den glaucomatösen Prozess. Graefes Arch Clin Exp Ophthalmol 4:456–650CrossRef

Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, Singh K (1991) Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 109:1090–1095. https://doi.org/10.1001/archopht.1991.01080080050026CrossRefPubMed

Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, Varotto A, Tenna V (1998) Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 105:209–215. https://doi.org/10.1016/s0161-6420(98)92665-3CrossRefPubMed

Kaiser HJ, Schoetzau A, Stumpfig D, Flammer J (1997) Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma. Am J Ophthalmol 123:320–327. https://doi.org/10.1016/s0002-9394(14)70127-8CrossRefPubMed

Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T, Kurysheva N, Yao K (2014) Flammer syndrome. EPMA J 5:11. https://doi.org/10.1186/1878-5085-5-11CrossRefPubMedPubMedCentral

Konieczka K, Choi HJ, Koch S, Fankhauser F, Schoetzau A, Kim DM (2017) Relationship between normal tension glaucoma and Flammer syndrome. EPMA J 8:111–117. https://doi.org/10.1007/s13167-017-0097-3CrossRefPubMedPubMedCentral

Barbosa-Breda J, Van Keer K, Abegao-Pinto L, Nassiri V, Molenberghs G, Willekens K, Vandewalle E, Rocha-Sousa A, Stalmans I (2019) Improved discrimination between normal-tension and primary open-angle glaucoma with advanced vascular examinations—the Leuven Eye Study. Acta Ophthalmol 97:e50–e56. https://doi.org/10.1111/aos.13809CrossRefPubMed

Drance SM (1972) Some factors in the production of low tension glaucoma. Br J Ophthalmol 56:229–242. https://doi.org/10.1136/bjo.56.3.229CrossRefPubMedPubMedCentral

Pillunat KR, Spoerl E, Jasper C, Furashova O, Hermann C, Borrmann A, Passauer J, Middeke M, Pillunat LE (2015) Nocturnal blood pressure in primary open-angle glaucoma. Acta Ophthalmol 93:e621–e626. https://doi.org/10.1111/aos.12740CrossRefPubMed

10.

Barthelmes J, Nagele MP, Ludovici V, Ruschitzka F, Sudano I, Flammer AJ (2017) Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences. EPMA J 8:99–109. https://doi.org/10.1007/s13167-017-0099-1CrossRefPubMedPubMedCentral

11.

Flammer J, Konieczka K (2017) The discovery of the Flammer syndrome: a historical and personal perspective. EPMA J 8:75–97. https://doi.org/10.1007/s13167-017-0090-xCrossRefPubMedPubMedCentral

12.

Orgul S, Kaiser HJ, Flammer J, Gasser P (1995) Systemic blood pressure and capillary blood-cell velocity in glaucoma patients: a preliminary study. Eur J Ophthalmol 5:88–91CrossRefPubMed

13.

Binggeli T, Schoetzau A, Konieczka K (2018) In glaucoma patients, low blood pressure is accompanied by vascular dysregulation. EPMA J 9:387–391. https://doi.org/10.1007/s13167-018-0155-5CrossRefPubMedPubMedCentral

14.

Levene RZ (1980) Low tension glaucoma: a critical review and new material. Surv Ophthalmol 24:621–664. https://doi.org/10.1016/0039-6257(80)90123-xCrossRefPubMed

15.

Kaiser HJ, Flammer J, Graf T, Stumpfig D (1993) Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 231:677–680. https://doi.org/10.1007/BF00919280CrossRefPubMed

16.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Group ESCSD (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39:3021–3104. https://doi.org/10.1093/eurheartj/ehy339CrossRefPubMed

17.

Osusky R, Rohr P, Schotzau A, Flammer J (2000) Nocturnal dip in the optic nerve head perfusion. Jpn J Ophthalmol 44:128–131. https://doi.org/10.1016/s0021-5155(99)00188-4CrossRefPubMed

18.

Gherghel D, Orgul S, Gugleta K, Flammer J (2001) Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure. Am J Ophthalmol 132:641–647. https://doi.org/10.1016/s0002-9394(01)01193-xCrossRefPubMed

19.

Pache M, Dubler B, Flammer J (2003) Peripheral vasospasm and nocturnal blood pressure dipping—two distinct risk factors for glaucomatous damage? Eur J Ophthalmol 13:260–265. https://doi.org/10.1177/112067210301300304CrossRefPubMed

20.

Werne A, Harris A, Moore D, BenZion I, Siesky B (2008) The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Surv Ophthalmol 53:559–567. https://doi.org/10.1016/j.survophthal.2008.08.021CrossRefPubMed

21.

Raman P, Suliman NB, Zahari M, Kook M, Ramli N (2018) Low nocturnal diastolic ocular perfusion pressure as a risk factor for NTG progression: a 5-year prospective study. Eye 32:1183–1189. https://doi.org/10.1038/s41433-018-0057-8CrossRefPubMedPubMedCentral

22.

Choi J, Kim KH, Jeong J, Cho HS, Lee CH, Kook MS (2007) Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci 48:104–111. https://doi.org/10.1167/iovs.06-0615CrossRefPubMed

23.

Choi J, Jeong J, Cho HS, Kook MS (2006) Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci 47:831–836. https://doi.org/10.1167/iovs.05-1053CrossRefPubMed

24.

Sung KR, Lee S, Park SB, Choi J, Kim ST, Yun SC, Kang SY, Cho JW, Kook MS (2009) Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci 50:5266–5274. https://doi.org/10.1167/iovs.09-3716CrossRefPubMed

25.

Lee J, Choi J, Jeong D, Kim S, Kook MS (2015) Relationship between daytime variability of blood pressure or ocular perfusion pressure and glaucomatous visual field progression. Am J Ophthalmol 160(e521):522–537e1. https://doi.org/10.1016/j.ajo.2015.05.034CrossRefPubMed

26.

Choi J, Lee JR, Lee Y, Lee KS, Na JH, Han S, Kook MS (2013) Relationship between 24-hour mean ocular perfusion pressure fluctuation and rate of paracentral visual field progression in normal-tension glaucoma. Invest Ophthalmol Vis Sci 54:6150–6157. https://doi.org/10.1167/iovs.13-12093CrossRefPubMed

27.

Sung KR, Cho JW, Lee S, Yun SC, Choi J, Na JH, Lee Y, Kook MS (2011) Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Invest Ophthalmol Vis Sci 52:737–743. https://doi.org/10.1167/iovs.10-5351CrossRefPubMed

28.

Marquardt R, Pillunat LE, Stodtmeister R (1988) Ocular hemodynamics following local administration of clonidine. Klin Monbl Augenheilkd 193:637–641. https://doi.org/10.1055/s-2008-1050311CrossRefPubMed

29.

Pillunat KR, Ventzke S, Spoerl E, Furashova O, Stodtmeister R, Pillunat LE (2014) Central retinal venous pulsation pressure in different stages of primary open-angle glaucoma. Br J Ophthalmol 98:1374–1378. https://doi.org/10.1136/bjophthalmol-2014-305126CrossRefPubMed

30.

Morgan WH, Hazelton ML, Azar SL, House PH, Yu DY, Cringle SJ, Balaratnasingam C (2004) Retinal venous pulsation in glaucoma and glaucoma suspects. Ophthalmology 111:1489–1494. https://doi.org/10.1016/j.ophtha.2003.12.053CrossRefPubMed

31.

Stodtmeister R, Ventzke S, Spoerl E, Boehm AG, Terai N, Haustein M, Pillunat LE (2013) Enhanced pressure in the central retinal vein decreases the perfusion pressure in the prelaminar region of the optic nerve head. Invest Ophthalmol Vis Sci 54:4698–4704. https://doi.org/10.1167/iovs.12-10607CrossRefPubMed

32.

Balaratnasingam C, Morgan WH, Hazelton ML, House PH, Barry CJ, Chan H, Cringle SJ, Yu DY (2007) Value of retinal vein pulsation characteristics in predicting increased optic disc excavation. Br J Ophthalmol 91:441–444. https://doi.org/10.1136/bjo.2006.105338CrossRefPubMed

33.

Morgan WH, Hazelton ML, Balaratnasingamm C, Chan H, House PH, Barry CJ, Cringle SJ, Yu DY (2009) The association between retinal vein ophthalmodynamometric force change and optic disc excavation. Br J Ophthalmol 93:594–596. https://doi.org/10.1136/bjo.2008.149963CrossRefPubMed

34.

Morgan WH, Balaratnasingam C, Hazelton ML, House PH, Cringle SJ, Yu DY (2005) The force required to induce hemivein pulsation is associated with the site of maximum field loss in glaucoma. Invest Ophthalmol Vis Sci 46:1307–1312. https://doi.org/10.1167/iovs.04-1126CrossRefPubMed

35.

Morgan WH (2013) Central venous pulsations: new findings, clinical importance and relation to cerebrospinal fluid pressure. J Glaucoma 22(Suppl 5):S15–S16. https://doi.org/10.1097/IJG.0b013e31829349d7CrossRefPubMed

36.

Legler U, Jonas JB (2009) Frequency of spontaneous pulsations of the central retinal vein in glaucoma. J Glaucoma 18:210–212. https://doi.org/10.1097/IJG.0b013e318182edd2CrossRefPubMed

37.

Seo JH, Kim TW, Weinreb RN, Kim YA, Kim M (2012) Relationship of intraocular pressure and frequency of spontaneous retinal venous pulsation in primary open-angle glaucoma. Ophthalmology 119:2254–2260. https://doi.org/10.1016/j.ophtha.2012.06.007CrossRefPubMed

38.

Abegao Pinto L, Vandewalle E, De Clerck E, Marques-Neves C, Stalmans I (2013) Lack of spontaneous venous pulsation: possible risk indicator in normal tension glaucoma? Acta Ophthalmol 91:514–520. https://doi.org/10.1111/j.1755-3768.2012.02472.xCrossRefPubMed

39.

Baertschi M, Dayhaw-Barker P, Flammer J (2016) The effect of hypoxia on intra-ocular, mean arterial, retinal venous and ocular perfusion pressures. Clin Hemorheol Microcirc 63:293–303. https://doi.org/10.3233/CH-152025CrossRefPubMed

40.

Fang L, Baertschi M, Mozaffarieh M (2014) The effect of flammer-syndrome on retinal venous pressure. BMC Ophthalmol 14:121. https://doi.org/10.1186/1471-2415-14-121CrossRefPubMedPubMedCentral

41.

Riva CE, Grunwald JE, Petrig BL (1986) Autoregulation of human retinal blood flow. An investigation with laser Doppler velocimetry. Invest Ophthalmol Vis Sci 27:1706–1712PubMed

42.

Pillunat LE, Stodtmeister R, Wilmanns I, Christ T (1985) Autoregulation of ocular blood flow during changes in intraocular pressure. Preliminary results. Graefes Arch Clin Exp Ophthalmol 223:219–223. https://doi.org/10.1007/bf02174065CrossRefPubMed

43.

Pillunat LE, Anderson DR, Knighton RW, Joos KM, Feuer WJ (1997) Autoregulation of human optic nerve head circulation in response to increased intraocular pressure. Exp Eye Res 64:737–744. https://doi.org/10.1006/exer.1996.0263CrossRefPubMed

44.

Fuchsjager-Mayrl G, Wally B, Georgopoulos M, Rainer G, Kircher K, Buehl W, Amoako-Mensah T, Eichler HG, Vass C, Schmetterer L (2004) Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 45:834–839. https://doi.org/10.1167/iovs.03-0461CrossRefPubMed

45.

Grunwald JE, Riva CE, Stone RA, Keates EU, Petrig BL (1984) Retinal autoregulation in open-angle glaucoma. Ophthalmology 91:1690–1694. https://doi.org/10.1016/s0161-6420(84)34091-xCrossRefPubMed

46.

Junemann AG, Huchzermeyer C, Rejdak R, Hohberger B (2014) Dyslipidaemia and glaucoma. Klin Monbl Augenheilkd 231:1203–1214. https://doi.org/10.1055/s-0034-1382964CrossRefPubMed

47.

Hayreh SS (1999) The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol 43(Suppl 1):S27–S42. https://doi.org/10.1016/s0039-6257(99)00018-1CrossRefPubMed

48.

Chen YY, Hu HY, Chu D, Chen HH, Chang CK, Chou P (2016) Patients with primary open-angle glaucoma May develop Ischemic heart disease more often than those without glaucoma: an 11-year population-based cohort study. PLoS ONE 11:e163210. https://doi.org/10.1371/journal.pone.0163210CrossRefPubMedPubMedCentral

49.

Jasper C (2016) Fettstoffwechselstörungen bei Patienten mit Offenwinkelglaukom. Ophthalmologe 113:13–192. https://doi.org/10.1007/s00347-016-0324-7CrossRef

50.

Zhu P, Dettmann ES, Resink TJ, Luscher TF, Flammer J, Haefliger IO (1999) Effect of Ox-LDL on endothelium-dependent response in pig ciliary artery: prevention by an ET(A) antagonist. Invest Ophthalmol Vis Sci 40:1015–1020PubMed

51.

(1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126: 487–497 https://doi.org/10.1016/s0002-9394(98)00223‑2

52.

Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z, Group E (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114:1965–1972. https://doi.org/10.1016/j.ophtha.2007.03.016CrossRefPubMed

53.

Costa VP, Harris A, Stefansson E, Flammer J, Krieglstein GK, Orzalesi N, Heijl A, Renard JP, Serra LM (2003) The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res 22:769–805. https://doi.org/10.1016/s1350-9462(03)00064-8CrossRefPubMed

54.

Siesky B, Harris A, Brizendine E, Marques C, Loh J, Mackey J, Overton J, Netland P (2009) Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow. Surv Ophthalmol 54:33–46. https://doi.org/10.1016/j.survophthal.2008.06.002CrossRefPubMed

55.

Gugleta K, Orgul S, Stumpfig D, Dubler B, Flammer J (1999) Fludrocortisone in the treatment of systemic hypotension in primary open-angle glaucoma patients. Int Ophthalmol 23:25–30. https://doi.org/10.1023/a:1006434231844CrossRefPubMed

56.

Pillunat LE, Spoerl E, Voigt E, Pillunat KR (2017) Effect of orally administered nitrates on central retinal venous pressure in primary open angle glaucoma patients. Invest Ophthalmol Vis Sci 58:731

57.

Emre M, Orgul S, Haufschild T, Shaw SG, Flammer J (2005) Increased plasma endothelin‑1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol 89:60–63. https://doi.org/10.1136/bjo.2004.046755CrossRefPubMedPubMedCentral

58.

Chauhan BC (2008) Endothelin and its potential role in glaucoma. Can J Ophthalmol 43:356–360. https://doi.org/10.3129/i08-060CrossRefPubMed

59.

Flammer J, Konieczka K (2015) Retinal venous pressure: the role of endothelin. EPMA J 6:21. https://doi.org/10.1186/s13167-015-0043-1CrossRefPubMedPubMedCentral

60.

Stein JD, Newman-Casey PA, Talwar N, Nan B, Richards JE, Musch DC (2012) The relationship between statin use and open-angle glaucoma. Ophthalmology 119:2074–2081. https://doi.org/10.1016/j.ophtha.2012.04.029CrossRefPubMed

61.

Marcus MW, Muskens RP, Ramdas WD, Wolfs RC, De Jong PT, Vingerling JR, Hofman A, Stricker BH, Jansonius NM (2012) Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study. Plos One 7:e29724. https://doi.org/10.1371/journal.pone.0029724CrossRefPubMedPubMedCentral

62.

Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS (2010) Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology 117:471–476. https://doi.org/10.1016/j.ophtha.2009.08.016CrossRefPubMed

63.

Oesterle A, Laufs U, Liao JK (2017) Pleiotropic effects of Statins on the cardiovascular system. Circ Res 120:229–243. https://doi.org/10.1161/CIRCRESAHA.116.308537CrossRefPubMedPubMedCentral

64.

Zhou Q, Liao JK (2010) Pleiotropic effects of statins.—Basic research and clinical perspectives. Circ J 74:818–826. https://doi.org/10.1253/circj.cj-10-0110CrossRefPubMedPubMedCentral

65.

Shahbaz SK, Sadeghi M, Koushki K, Penson PE, Sahebkar A (2019) Regulatory T cells: possible mediators for the anti-inflammatory action of statins. Pharmacol Res 149:104469. https://doi.org/10.1016/j.phrs.2019.104469CrossRefPubMed

66.

Pillunat LE, Kuba GB, Harris A (1996) Ocular vasospasm and calcium channel blockers in glaucoma. In: Bucci MG (Hrsg) Glaucoma: decision making in therapy. Springer, Berlin

67.

Strenn K, Matulla B, Wolzt M, Findl O, Bekes MC, Lamsfuss U, Graselli U, Rainer G, Menapace R, Eichler HG, Schmetterer L (1998) Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther 63:54–63. https://doi.org/10.1016/S0009-9236(98)90121-7CrossRefPubMed

68.

Fang L, Turtschi S, Mozaffarieh M (2015) The effect of nifedipine on retinal venous pressure of glaucoma patients with the Flammer-Syndrome. Graefes Arch Clin Exp Ophthalmol 253:935–939. https://doi.org/10.1007/s00417-015-3001-7CrossRefPubMed

69.

Gasser P, Flammer J (1990) Short- and long-term effect of nifedipine on the visual field in patients with presumed vasospasm. J Int Med Res 18:334–339. https://doi.org/10.1177/030006059001800411CrossRefPubMed

70.

Geyer O, Neudorfer M, Kessler A, Firsteter E, Lazar M, Almog Y (1996) Effect of oral nifedipine on ocular blood flow in patients with low tension glaucoma. Br J Ophthalmol 80:1060–1062. https://doi.org/10.1136/bjo.80.12.1060CrossRefPubMedPubMedCentral

71.

Harris A, Evans DW, Cantor LB, Martin B (1997) Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma. Am J Ophthalmol 124:296–302. https://doi.org/10.1016/s0002-9394(14)70821-9CrossRefPubMed

72.

Rainer G, Kiss B, Dallinger S, Findl O, Georgopoulos M, Vass C, Menapace R, Polak K, Eichler HG, Wolzt M, Schmetterer L (2001) A double masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma. Br J Clin Pharmacol 52:210–212. https://doi.org/10.1046/j.0306-5251.2001.01432.xCrossRefPubMedPubMedCentral

73.

Michalk F, Michelson G, Harazny J, Werner U, Daniel WG, Werner D (2004) Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma. J Glaucoma 13:158–162. https://doi.org/10.1097/00061198-200404000-00013CrossRefPubMed

74.

Boehm AG, Breidenbach KA, Pillunat LE, Bernd AS, Mueller MF, Koeller AU (2003) Visual function and perfusion of the optic nerve head after application of centrally acting calcium-channel blockers. Graefes Arch Clin Exp Ophthalmol 241:34–38. https://doi.org/10.1007/s00417-002-0592-6CrossRefPubMed

75.

Böhm AGPL (1999) Kalziumantagonisten in der Langzeittherapie des Normalsdruckglaukoms. In: Schmidt KGPL (Hrsg) Fortbildung Glaukom, Bd a, Perfusion und Pharmakologie. Enke, Stuttgart

76.

Piltz JR, Bose S, Lanchoney D (1998) The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma 7:336–342CrossRefPubMed

77.

Bose S, Piltz JR, Breton ME (1995) Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects. Ophthalmology 102:1236–1241. https://doi.org/10.1016/s0161-6420(95)30884-6CrossRefPubMed

78.

Werner GS, Figulla HR (2002) Direct assessment of coronary steal and associated changes of collateral hemodynamics in chronic total coronary occlusions. Circulation 106:435–440. https://doi.org/10.1161/01.cir.0000022848.92729.33CrossRefPubMed

79.

Becker LC (1978) Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 57:1103–1110. https://doi.org/10.1161/01.cir.57.6.1103CrossRefPubMed

80.

Gaspar AZ, Gasser P, Flammer J (1995) The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 209:11–13. https://doi.org/10.1159/000310566CrossRefPubMed

81.

Dettmann ES, Luscher TF, Flammer J, Haefliger IO (1998) Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries. Graefes Arch Clin Exp Ophthalmol 236:47–51. https://doi.org/10.1007/s004170050041CrossRefPubMed

82.

Ramdas WD, Wolfs RC, Kiefte-de JJC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM (2012) Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study. Eur J Epidemiol 27:385–393. https://doi.org/10.1007/s10654-012-9672-zCrossRefPubMedPubMedCentral

83.

Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F (2004) The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res 28:153–157. https://doi.org/10.1076/ceyr.28.3.153.26246CrossRefPubMed

84.

Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E (2003) Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 110:359–362. https://doi.org/10.1016/S0161-6420(02)01745-1 (discussion 362–354)CrossRefPubMed

85.

Cybulska-Heinrich A, Mozaffarieh M, Flammer J (2013) Value of non-IOP lowering therapy for glaucoma. Klin Monbl Augenheilkd 230:114–119. https://doi.org/10.1055/s-0032-1327825CrossRefPubMed

86.

Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R (1999) Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther 15:233–240. https://doi.org/10.1089/jop.1999.15.233CrossRefPubMed

87.

Yip JL, Broadway DC, Luben R, Garway-Heath DF, Hayat S, Dalzell N, Lee PS, Bhaniani A, Wareham NJ, Khaw KT, Foster PJ (2011) Physical activity and ocular perfusion pressure: the EPIC-Norfolk eye study. Invest Ophthalmol Vis Sci 52:8186–8192. https://doi.org/10.1167/iovs.11-8267CrossRefPubMed

Titel: Vaskuläre Therapiekonzepte bei Glaukompatienten
verfasst von: Priv.-Doz. Dr. med. Karin R. Pillunat
Lutz E. Pillunat
Publikationsdatum: 07.10.2020
Verlag: Springer Medizin
Schlagwörter: Glaukom
Kalziumantagonisten
Statine
Erschienen in: Die Ophthalmologie / Ausgabe 5/2021
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-020-01239-7

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Vaskuläre Therapiekonzepte bei Glaukompatienten

Zusammenfassung

Hintergrund

Fragestellung

Material und Methode

Ergebnisse

Schlussfolgerung

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Zusammenfassung

Hintergrund

Fragestellung

Material und Methode

Ergebnisse

Schlussfolgerung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Differenzialdiagnose bei Papillenschwellung und makulärer Exsudation – das exophytisch wachsende juxtapapilläre retinale kapilläre Hämangiom

Resektion einer submakulären Traktionsmembran bei ausgeprägter Visusminderung

Neue therapeutische Konzepte in der Glaukomtherapie

Wie gut sehen unsere ABC-Schützen?

Rho-Kinase-Hemmer als neue lokale Therapieoption beim primären Offenwinkelglaukom

Diagnostik und Grading intraokulärer Lymphome

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde